Industry Experts

PhD-level molecular biologist and virologist with more than 17 years of combined experience in academia and industry, complemented by strong leadership capabilities. I currently lead a cross-functional team of 40 researchers conducting both platform- and program-specific research (liver, CNS, and muscle) to continuously advance and invest in Ultragenyx’s gene therapy platforms and programs.

I volunteer as a member of the FNIH Bespoke Gene Therapy Consortium (BGTC) Steering Committee and the AAV Biology Subteam, and I serve on the scientific advisory boards for the Coalition to Cure CHD2 (CCC), IDefine (Kleefstra Syndrome), and the Myhre Syndrome Foundation (MSF), as well as Chief Scientific Advisor for the Cohen Syndrome Research Foundation (CSRF). Additionally, I serve on the Education Committee and Patient Outreach Committee for the American Society for Gene and Cell Therapy.